Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-10-02

FDA Approved: VIGABATRIN — Supplemental Application (Cipla USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Vigabatrin by Cipla USA, Inc., granting an additional approval under the ANDA for Vigabatrin, typically involving an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vigabatrin (Vigabatrin)

Snippet

SUPPL AP for VIGABATRIN (VIGABATRIN)